Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
295.63 -9.37 (-3.07%) 15:04 ET [NASDAQ]
295.00 x 200 296.08 x 97
Realtime by (Cboe BZX)
295.00 x 200 296.08 x 97
Realtime - - (-) -
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
295.25
Day High
305.77
Open 305.00
Previous Close 305.00 305.00
Volume 390,361 390,361
Avg Vol 552,077 552,077
Stochastic %K 61.52% 61.52%
Weighted Alpha -23.96 -23.96
5-Day Change -5.76 (-1.90%) -5.76 (-1.90%)
52-Week Range 271.99 - 459.77 271.99 - 459.77
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,219,540
  • Shares Outstanding, K 30,228
  • Annual Sales, $ 2,109 M
  • Annual Income, $ 404,390 K
  • EBIT $ 476 M
  • EBITDA $ 505 M
  • 60-Month Beta 1.46
  • Price/Sales 4.38
  • Price/Cash Flow 21.88
  • Price/Book 11.49

Options Overview Details

View History
  • Implied Volatility 65.82% ( +2.16%)
  • Historical Volatility 50.83%
  • IV Percentile 98%
  • IV Rank 89.65%
  • IV High 70.52% on 04/11/25
  • IV Low 25.18% on 08/23/24
  • Put/Call Vol Ratio 5.33
  • Today's Volume 19
  • Volume Avg (30-Day) 139
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 3,193
  • Open Int (30-Day) 1,987

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 3.06
  • Number of Estimates 5
  • High Estimate 3.16
  • Low Estimate 2.89
  • Prior Year 3.20
  • Growth Rate Est. (year over year) -4.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
271.99 +9.12%
on 04/09/25
Period Open: 324.95
331.24 -10.40%
on 03/24/25
-28.15 (-8.66%)
since 03/14/25
3-Month
271.99 +9.12%
on 04/09/25
Period Open: 336.82
375.00 -20.85%
on 02/06/25
-40.02 (-11.88%)
since 01/16/25
52-Week
271.99 +9.12%
on 04/09/25
Period Open: 385.05
459.77 -35.44%
on 07/17/24
-88.24 (-22.92%)
since 04/16/24

Most Recent Stories

More News
1 Spectacular Growth Stock Down 34% to Buy Hand Over Fist

Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical industry exposed to the broader market's whims. One less stressful way to take...

MEDP : 295.63 (-3.07%)
3 Market-Beating Stocks with Solid Fundamentals

3 Market-Beating Stocks with Solid Fundamentals

MEDP : 295.63 (-3.07%)
EXLS : 45.14 (-1.63%)
DUOL : 320.44 (-1.45%)
How Is Charles River Laboratories' Stock Performance Compared to Other Health Care Stocks?

As Charles River Laboratories has underperformed its industry peers recently, analysts remain cautious about the stock’s prospects.

MEDP : 295.63 (-3.07%)
XLV : 136.26 (-1.04%)
CRL : 104.43 (-1.41%)
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore

1 Healthcare Stock with Solid Fundamentals and 2 to Ignore

MEDP : 295.63 (-3.07%)
PDCO : 31.33 (+0.03%)
PRVA : 23.94 (-1.03%)
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 295.63 (-3.07%)
FTRE : 5.11 (+5.14%)
AZTA : 25.11 (-3.09%)
RGEN : 130.23 (+2.85%)
CRL : 104.43 (-1.41%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 5.11 (+5.14%)
MEDP : 295.63 (-3.07%)
AZTA : 25.11 (-3.09%)
WST : 208.99 (-1.65%)
IQV : 148.25 (-0.60%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 5.11 (+5.14%)
MEDP : 295.63 (-3.07%)
RGEN : 130.23 (+2.85%)
AZTA : 25.11 (-3.09%)
IQV : 148.25 (-0.60%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 5.11 (+5.14%)
MEDP : 295.63 (-3.07%)
AZTA : 25.11 (-3.09%)
CRL : 104.43 (-1.41%)
IQV : 148.25 (-0.60%)
2 Reasons to Watch MEDP and 1 to Stay Cautious

2 Reasons to Watch MEDP and 1 to Stay Cautious

MEDP : 295.63 (-3.07%)
Why Medpace (MEDP) Shares Are Trading Lower Today

Why Medpace (MEDP) Shares Are Trading Lower Today

MEDP : 295.63 (-3.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 313.79
2nd Resistance Point 310.40
1st Resistance Point 307.70
Last Price 295.63
1st Support Level 301.60
2nd Support Level 298.21
3rd Support Level 295.51

See More

52-Week High 459.77
Fibonacci 61.8% 388.04
Fibonacci 50% 365.88
Fibonacci 38.2% 343.72
Last Price 295.63
52-Week Low 271.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro